These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 18201301

  • 1. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS.
    Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
    [Abstract] [Full Text] [Related]

  • 2. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ, Glasson C, O'Flaherty SJ.
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [Abstract] [Full Text] [Related]

  • 3. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and duration of botulinum toxin treatment for drooling in 131 children.
    Scheffer AR, Erasmus C, van Hulst K, van Limbeek J, Jongerius PH, van den Hoogen FJ.
    Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):873-7. PubMed ID: 20855679
    [Abstract] [Full Text] [Related]

  • 5. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ, Jongerius PH, Van Hulst K, Van Limbeek J, Rotteveel JJ.
    Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B, Aslami B, Backes H.
    Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
    [Abstract] [Full Text] [Related]

  • 7. Thickened saliva after effective management of drooling with botulinum toxin A.
    Erasmus CE, Van Hulst K, Van Den Hoogen FJ, Van Limbeek J, Roeleveld N, Veerman EC, Rotteveel JJ, Jongerius PH.
    Dev Med Child Neurol; 2010 Jun; 52(6):e114-8. PubMed ID: 20163435
    [Abstract] [Full Text] [Related]

  • 8. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S.
    Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
    [Abstract] [Full Text] [Related]

  • 9. Successful management of drooling with botulinum toxin A in neurologically disabled children.
    Ellies M, Rohrbach-Volland S, Arglebe C, Wilken B, Laskawi R, Hanefeld F.
    Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
    [Abstract] [Full Text] [Related]

  • 10. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
    Alrefai AH, Aburahma SK, Khader YS.
    Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
    [Abstract] [Full Text] [Related]

  • 11. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawi R.
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [Abstract] [Full Text] [Related]

  • 12. The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities.
    Reid SM, Johnson HM, Reddihough DS.
    Dev Med Child Neurol; 2010 Feb; 52(2):e23-8. PubMed ID: 19843155
    [Abstract] [Full Text] [Related]

  • 13. [The efficacy of botulinum toxin-A in the treatment of hypersalivation in children with cerebral palsy].
    Alataş N, Yazgan P, Oztürk A, San I.
    Kulak Burun Bogaz Ihtis Derg; 2006 Feb; 16(2):49-53. PubMed ID: 16763416
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
    Basciani M, Di Rienzo F, Fontana A, Copetti M, Pellegrini F, Intiso D.
    Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974
    [Abstract] [Full Text] [Related]

  • 15. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling.
    Reid SM, Walstab JE, Chong D, Westbury C, Reddihough DS.
    J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.
    Int J Pediatr Otorhinolaryngol; 2016 Sep; 88():142-5. PubMed ID: 27497402
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT, Doherty GM, Fairhurst CB.
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin injections for children with excessive drooling.
    Hassin-Baer S, Scheuer E, Buchman AS, Jacobson I, Ben-Zeev B.
    J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
    [Abstract] [Full Text] [Related]

  • 19. Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy.
    Sriskandan N, Moody A, Howlett DC.
    Br J Oral Maxillofac Surg; 2010 Jan; 48(1):58-60. PubMed ID: 19371986
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
    Wu KP, Ke JY, Chen CY, Chen CL, Chou MY, Pei YC.
    J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.